ESSA Pharma
Price & Volume
Stats
See more52W Range | $1.40-$11.67 |
Market Cap | $71M |
Shares Short | 691,472 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.64 |
News
See moreYahoo Finance • 11 months ago
ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium
Yahoo Finance • last year
ESSA Pharma to Present at the Jefferies London Healthcare Conference
Yahoo Finance • 2 years ago
Summit Therapeutics Appoints Experienced Clinical Leader Dr. Alessandra Cesano to its Board of Directors
Yahoo Finance • 2 years ago
ESSA Pharma to Participate in Two Upcoming Investor Conferences
About
CEO | Dr. David Ross Parkinson M.D. |
Address | 999 West Broadway, Vancouver, BC, Canada, V5Z 1K5 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 50 |
